The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2022
DOI: 10.1155/2022/6858962
|View full text |Cite
|
Sign up to set email alerts
|

Upper Extremity Function following Transradial Percutaneous Coronary Intervention: Results of the ARCUS Trial

Abstract: Objectives. To determine the incidence of upper extremity dysfunction (UED), after a transradial percutaneous coronary intervention (TR-PCI). Background. Transradial approach (TRA) is the preferred approach for coronary interventions. However, upper extremity complications may be underreported. Methods. The ARCUS was designed as a prospective cohort study, including 502 consecutive patients admitted for PCI. Patients treated with transfemoral PCI (TF-PCI) acted as a control group. A composite score of physical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 24 publications
(25 reference statements)
0
2
0
Order By: Relevance
“…Former literature showed an incidence varying from 1.7-75%. 3,5,20,21 With a power of 0.8, alpha of 0.05, an estimated incidence of 30% in the conventional group, and an estimated relative decrease of 30% in the slender group, a total group of at least 190 patients is required to achieve statistical significance for the primary endpoint. The following baseline characteristics have been recorded: age, sex, dominant hand, smoking status (where smoking is defined as current smoking or stopped ≤6 months before procedure), diabetes mellitus, hypertension, body mass index, use of beta blockers and statins, previous ipsilateral radial access, pre-procedural UED (QuickDASH), pre-procedural CI (CISS).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Former literature showed an incidence varying from 1.7-75%. 3,5,20,21 With a power of 0.8, alpha of 0.05, an estimated incidence of 30% in the conventional group, and an estimated relative decrease of 30% in the slender group, a total group of at least 190 patients is required to achieve statistical significance for the primary endpoint. The following baseline characteristics have been recorded: age, sex, dominant hand, smoking status (where smoking is defined as current smoking or stopped ≤6 months before procedure), diabetes mellitus, hypertension, body mass index, use of beta blockers and statins, previous ipsilateral radial access, pre-procedural UED (QuickDASH), pre-procedural CI (CISS).…”
Section: Discussionmentioning
confidence: 99%
“…Our explanation is that, by the use of multiple and elaborated tests, and the lack of a MICD threshold, the incidence of postprocedural UED might have been previously overestimated beyond clinical relevance. [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] By using QuickDASH, and setting MICD at 8, we knowingly chose for an easy and yet reliable tool. In our experience, and after correction for confounders, slender TRA procedures showed a lower incidence of early (2 weeks) post-procedural UED.…”
Section: Discussionmentioning
confidence: 99%